Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue International Journal of Pharmaceutics Année : 2006

Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride

Résumé

A novel oral controlled delivery system for propranolol hydrochloride (PPL) was developed and optimized. The in vitro dissolution profiles of sustained-release matrix tablets of racemic PPL were determined and compared with the United States Pharmacopeia (USP) tolerance specifications for Propranolol Hydrochloride Extended-Release Capsules. The influence of matrix forming agents (native dextran, hydroxypropyl methylcellulose (HPMC), cetyl alcohol) and binary mixtures of them on PPL release in vitro was investigated. A central composite design was applied to the optimization of a sustained-release tablet formulation. The sustained-release matrix tablets with good physical, mechanical and technological properties were obtained with a matrix excipient:PPL ratio of 60:40 (w/w), with a dextran:HPMC ratio of 4:1 (w/w) and with a cetyl alcohol amount of 15% (w/w). A comparative kinetic study of the present matrix tablets and commercial SUMIAL RETARD capsules (Spain) was established. The value for the similarity factor (f2 = 69.6) suggested that the dissolution profile of the present two sustained-release oral dosage forms are similar. Higuchi (diffusion) and Hixon–Crowell (erosion) kinetic profiles were achieved and this codependent mechanism of drug release was established.

Domaines

Matériaux
Fichier principal
Vignette du fichier
Castellanos_Gil_2690.pdf (516.85 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03595642 , version 1 (03-03-2022)

Identifiants

Citer

Eddy Castellanos Gil, Antonio Iraizoz Colarte, Bernard Bataille, José Luis Pedraz, Fernand Rodriguez, et al.. Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride. International Journal of Pharmaceutics, 2006, 317 (1), pp.32-39. ⟨10.1016/j.ijpharm.2006.02.049⟩. ⟨hal-03595642⟩
5 Consultations
33 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More